CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.

dc.contributor.authorCañada García, Javier E.
dc.contributor.authorMoure, Zaira
dc.contributor.authorSola Campoy, Pedro J.
dc.contributor.authorDelgado Valverde, Mercedes
dc.contributor.authorCano, María E.
dc.contributor.authorGijón Cordero, Desirée
dc.contributor.authorGonzález, Mónica
dc.contributor.authorGracia Ahufinger, Irene
dc.contributor.authorLarrosa, Nieves
dc.contributor.authorMulet, Xavier
dc.contributor.authorPitart, Cristina
dc.contributor.authorRivera, Alba
dc.contributor.authorBou, Germán
dc.contributor.authorCalvo, Jorge
dc.contributor.authorCantón, Rafael
dc.contributor.authorGonzález-López, Juan José
dc.contributor.authorMartínez-Martínez, Luis
dc.contributor.authorNavarro, Ferran
dc.contributor.authorOliver, Antonio
dc.contributor.authorPalacios Baena, Zaira R.
dc.contributor.authorPascual, Alvaro
dc.contributor.authorRuiz Carrascoso, Guillermo
dc.contributor.authorVila Estapé, Jordi
dc.contributor.authorAracil, Belén
dc.contributor.authorPérez-Vázquez, María
dc.contributor.authorOteo Iglesias, Jesús
dc.contributor.authorGEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group
dc.date.accessioned2022-11-29T16:03:47Z
dc.date.available2022-11-29T16:03:47Z
dc.date.issued2022-06-30
dc.date.updated2022-11-29T16:03:47Z
dc.description.abstractCARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were bla OXA-48 (263/377), bla KPC-3 (62/377), bla VIM-1 (28/377), and bla NDM-1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec725629
dc.identifier.issn1664-302X
dc.identifier.pmid35847090
dc.identifier.urihttps://hdl.handle.net/2445/191256
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fmicb.2022.918362
dc.relation.ispartofFrontiers in Microbiology, 2022, vol. 13, p. 918362
dc.relation.urihttps://doi.org/10.3389/fmicb.2022.918362
dc.rightscc-by (c) Cañada García, Javier E. et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Fonaments Clínics)
dc.subject.classificationAntibiòtics betalactàmics
dc.subject.classificationKlebsiella pneumoniae
dc.subject.classificationEscheríchia coli
dc.subject.classificationGenoma humà
dc.subject.classificationEnterobacteriàcies
dc.subject.otherBeta lactam antibiotics
dc.subject.otherKlebsiella pneumoniae
dc.subject.otherEscherichia coli
dc.subject.otherHuman genome
dc.subject.otherEnterobacteriaceae
dc.titleCARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
725629.pdf
Mida:
3.73 MB
Format:
Adobe Portable Document Format